ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00414648
Recruitment Status : Unknown
Verified August 2009 by Office of Rare Diseases (ORD).
Recruitment status was:  Active, not recruiting
First Posted : December 21, 2006
Last Update Posted : August 28, 2009
Sponsor:
Collaborator:
FDA Office of Orphan Products Development
Information provided by:
Office of Rare Diseases (ORD)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2010
  Estimated Study Completion Date : September 2011
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):